1. Barnett K, McCowan C, Evans JM, Gillespie ND, Davey PG, Fahey T.
Prevalence and outcomes of use of potentially inappropriate
medicines in older people: Cohort study stratified by residence in
nursing home or in the community. BMJ Qual Saf 2011;20:275‑81.
2. Büla C. Medication usage in the elderly: Outrage and delight. Rev
Med Suisse 2011;7:2163‑4.
3. De Grey, A.D., The desperate need for a biomedically useful
definition of “aging”. Rejuvenation Res 2013;16:89‑90.
4. Diamond J. Population history: Human melting pots in Southeast
Asia. Nature 2014;512:262‑3.
5. Eckardt R, Steinhagen‑Thiessen E, Kämpfe S, Buchmann N.
Polypharmacy and drug prescription in the elderly. Strategies for
optimization. Z Gerontol Geriatr 2014;47:293‑301.
6. Golestannejad A. Isfahan Statstical Year Book. Vol. 1. Isfahan:
Isfahan Municipality; 2013. p. 41‑92.
7. Huber M, Blumberg A, Chatterjee S, Haenisch B, Schlosser‑Weber G,
Broich K. Drug safety: Challenge in an aging society. Nervenarzt
2014;85:1352‑62.
8. Imani‑Nasab MH, Seyedin H, Majdzadeh R, Yazdizadeh B, Salehi M.
Development of evidence‑based health policy documents
in developing countries: A case of Iran. Glob J Health Sci
2014;6:27‑36.
9. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy
in elderly patients with and without acute coronary syndromes.
JAMA 2002;288:462‑7.
10. Lo, R., Geriatric pharmacotherapy: Problems with adherence. Int J
Psychiatr Nurs Res 2001;7:806‑14.
11. Normand SL, Zou KH. Sample size considerations in observational
health care quality studies. Stat Med 2002;21:331‑45.
12. Morisky DE, Ang A, Krousel‑Wood M, Ward HJ. Predictive validity
of a medication adherence measure in an outpatient setting. J Clin
Hypertens (Greenwich) 2008;110:348‑54.
13. Mårdby AC, Akerlind I, Hedenrud T. General beliefs about medicines
among doctors and nurses in out‑patient care: A cross‑sectional
study. BMC Fam Pract 2009;10:35.
14. Miller CA. Nursing for Wellness in Older Adults, Latin Book. 5th ed.
Philadelphia: Publish by Wolters Kluwer Health/Lippincott Williams
& Wilkins; 2009. p. 305‑408.
15. Maher RL, Hanlon J, Hajjar ER. Clinical consequences of
polypharmacy in elderly. Expert Opin Drug Saf 2014;13:57‑65.
16. McLaughlin SJ. A Public Health Approach to the Challenges of an
Aging Society. Gerontologist 2014; 9(7):723‑34.
17. Merchant EK. Global population: History, geopolitics, and life on
earth. Glob Public Health 2015;10:129‑31.
18. Mannucci PM, Nobili A, REPOSI Investigators. Multimorbidity and
polypharmacy in the elderly: Lessons from REPOSI. Intern Emerg
Med 2014;9:723‑34.
19. Son KY, Park SM, Lee J, Kim CY. Difference in adherence to and
influencing factors of a healthy lifestyle between middle‑aged and
elderly people in Korea: A multilevel analysis. Geriatr Gerontol Int
2014; Geriatrics & Gerontology International, 2014: p. 1‑11. PMID:
25256663.
20. Shokri S. The Compliance of Dialysis Patients with their Treatment
Regimens [Thesis for PharmD degree], in Department of Clinical
Pharmacy and Pharmacy Practice. Iran: Isfahan University of Medical
Sciences; 2009. p. 94.
21. Shariatirad S, Maarefvand M. Sanctions against Iran and the
impact on drug use and addiction treatment. Int J Drug Policy
2013;24:636‑7.
22. Tsai KT, Chen JH, Wen CJ, Kuo HK, Lu IS, Chiu LS, et al. Medication
adherence among geriatric outpatients prescribed multiple
medications. Am J Geriatr Pharmacother 2012;10:61‑8.